Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - H&R Block (NYSE: HRB) reported fourth quarter EPS of $5.38, $0.13 better than the analyst estimate of $5.25. Revenue for the quarter came in at $2.3B versus the consensus estimate of $2.26B.
Guidance
H&R Block sees FY 2025 EPS of $5.15-$5.35 versus the analyst consensus of $5.28.
H&R Block sees FY 2025 revenue of $3.69B-$3.75B versus the analyst consensus of $3.72B.
H&R Block’s stock price closed at $61.68. It is up 15.90% in the last 3 months and up 27.10% in the last 12 months.
H&R Block saw 0 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See H&R Block’s stock price’s past reactions to earnings here.
According to InvestingPro, H&R Block’s Financial Health score is "great performance".
Check out H&R Block’s recent earnings performance, and H&R Block’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar